Dr. Perentesis is an active clinical and translational investigator in developmental therapeutics for pediatric cancers, with significant national leadership roles in national cancer research organizations, including:

  • Investigational Drug Steering Committee (IDSC) of the National Cancer Institute (NCI) Cancer Therapy Evaluation Program (CTEP): Member of the Steering Committee; Co-Chair, Signal Transduction Agents Task Force
  • Pediatric Developmental Therapeutics/Phase I Consortium: Member, National Steering Committee, currently vice chair of clinical studies ADVL0813 and ADVL0414
  • Children’s Oncology Group (COG): Member, COG Executive Committee; Chair, Acute Myeloid Leukemia Relapse Committee; Member, Myeloid Diseases Steering Group; Vice Chair, Adolescent and Young Adult Cancer Steering Committee; Member, Institutional Performance Monitoring Committee
  • Department of Defense Neurofibromatosis Clinical Therapeutics Consortium: Chair, Malignant Peripheral Nerve Sheath Tumor Translational Therapies Committee